Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Matet

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
European Radiology|August 6, 2025
Practical guidelines on imaging of retinoblastoma: a 2025 update on behalf of the European Retinoblastoma Imaging Collaboration and the European Retinoblastoma GroupLiesbeth Cardoen, Selma Sirin, Paolo Galuzzi, et al.
Journal of the National Cancer Institute|April 3, 2020
Germline MBD4 Mutations and Predisposition to Uveal MelanomaAnne-Céline Derrien, Manuel Rodrigues, Alexandre Eeckhoutte, et al.
The Journal of Molecular Diagnostics : JMD|October 17, 2021
Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and BiomarkersJessica Le Gall, Catherine Dehainault, Camille Benoist, et al.
JAMA Ophthalmology|April 30, 2026
Prevalence of the Predisposing Gene MBD4 for Uveal MelanomaAnaïs Le Ven, Marie-Charlotte Villy, Marine Le Mentec, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 7, 2022
L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastasesRaymond Barnhill, Steven van Laere, Peter Vermeulen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 16, 2025
A functional assay to classify RB1 variants of uncertain significanceJessica Le Gall, Catherine Dehainault, Ambre Petitalot, et al.
Ophthalmology Science|December 11, 2025
Genetic Background Predicts Uveal Melanoma Patients' OutcomesThibault Verrier, Anaïs Le Ven, Alexandre Houy, et al.
British Journal of Cancer|July 13, 2023
Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastasesPascale Mariani, Nouritza Torossian, Steven van Laere, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patientsMathilde Saint-Ghislain, Anne-Céline Derrien, Lionnel Geoffrois, et al.
The Journal of Pathology|January 24, 2025
SMARCB1-deficient malignant melanocytic uveal tumours: a new neural crest-derived tumour entity with SMARCB1-related germline predispositionJoanna Cyrta, Julien Masliah-Planchon, Owen Hoare, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
European Radiology|August 6, 2025
Practical guidelines on imaging of retinoblastoma: a 2025 update on behalf of the European Retinoblastoma Imaging Collaboration and the European Retinoblastoma GroupLiesbeth Cardoen, Selma Sirin, Paolo Galuzzi, et al.
Journal of the National Cancer Institute|April 3, 2020
Germline MBD4 Mutations and Predisposition to Uveal MelanomaAnne-Céline Derrien, Manuel Rodrigues, Alexandre Eeckhoutte, et al.
The Journal of Molecular Diagnostics : JMD|October 17, 2021
Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and BiomarkersJessica Le Gall, Catherine Dehainault, Camille Benoist, et al.
JAMA Ophthalmology|April 30, 2026
Prevalence of the Predisposing Gene MBD4 for Uveal MelanomaAnaïs Le Ven, Marie-Charlotte Villy, Marine Le Mentec, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 7, 2022
L1CAM and laminin vascular network: Association with the high-risk replacement histopathologic growth pattern in uveal melanoma liver metastasesRaymond Barnhill, Steven van Laere, Peter Vermeulen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 16, 2025
A functional assay to classify RB1 variants of uncertain significanceJessica Le Gall, Catherine Dehainault, Ambre Petitalot, et al.
Ophthalmology Science|December 11, 2025
Genetic Background Predicts Uveal Melanoma Patients' OutcomesThibault Verrier, Anaïs Le Ven, Alexandre Houy, et al.
British Journal of Cancer|July 13, 2023
Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastasesPascale Mariani, Nouritza Torossian, Steven van Laere, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patientsMathilde Saint-Ghislain, Anne-Céline Derrien, Lionnel Geoffrois, et al.
The Journal of Pathology|January 24, 2025
SMARCB1-deficient malignant melanocytic uveal tumours: a new neural crest-derived tumour entity with SMARCB1-related germline predispositionJoanna Cyrta, Julien Masliah-Planchon, Owen Hoare, et al.
Pageof 9